Congenital long QT syndrome

AD Krahn, Z Laksman, RW Sy, PG Postema… - Clinical …, 2022 - jacc.org
Congenital long QT syndrome (LQTS) encompasses a group of heritable conditions that are
associated with cardiac repolarization dysfunction. Since its initial description in 1957, our …

Electroimmunology and cardiac arrhythmia

J Grune, M Yamazoe, M Nahrendorf - Nature reviews cardiology, 2021 - nature.com
Conduction disorders and arrhythmias remain difficult to treat and are increasingly prevalent
owing to the increasing age and body mass of the general population, because both are risk …

NaV1. 5 autoantibodies in Brugada syndrome: pathogenetic implications

A Tarantino, G Ciconte, D Melgari, A Frosio… - European heart …, 2024 - academic.oup.com
Abstract Background and Aims Patients suffering from Brugada syndrome (BrS) are
predisposed to life-threatening cardiac arrhythmias. Diagnosis is challenging due to the …

The efficacy of Beta-blockers in patients with Long QT Syndrome 1–3 according to individuals' gender, Age, and QTc intervals: A Network Meta-analysis

L Han, F Liu, Q Li, T Qing, Z Zhai, Z Xia… - Frontiers in …, 2020 - frontiersin.org
Long QT syndrome (LQTS) is an arrhythmic heart disease caused by congenital genetic
mutations, and results in increased occurrence rates of polymorphic ventricular …

Cellular and electrophysiological characterization of triadin knockout syndrome using induced pluripotent stem cell-derived cardiomyocytes

DJ Clemens, D Ye, L Wang, CSJ Kim, W Zhou… - Stem Cell Reports, 2023 - cell.com
Triadin knockout syndrome (TKOS) is a malignant arrhythmia disorder caused by recessive
null variants in TRDN-encoded cardiac triadin. Induced pluripotent stem cell-derived …

The role of autoantibodies in arrhythmogenesis

J Li - Current cardiology reports, 2021 - Springer
Abstract Purpose of Review The role of autoantibodies in arrhythmogenesis has been the
subject of research in recent times. This review focuses on the rapidly expanding field of …

Endocannabinoids enhance hKV7. 1/KCNE1 channel function and shorten the cardiac action potential and QT interval

I Hiniesto-Iñigo, LM Castro-Gonzalez, V Corradi… - …, 2023 - thelancet.com
Background Genotype-positive patients who suffer from the cardiac channelopathy Long QT
Syndrome (LQTS) may display a spectrum of clinical phenotypes, with often unknown …

Computational analysis of long QT syndrome type 2 and the therapeutic effects of KCNQ1 antibodies

Z Pan, Q Fu, H Jiang, Z Wei, S Zhang - Digital Health, 2024 - journals.sagepub.com
Objective Long QT interval syndrome (LQTS) is a highly dangerous cardiac disease that can
lead to sudden cardiac death; however, its underlying mechanism remains largely unknown …

Targeting the IKs Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants

L Zhong, Z Yan, D Jiang, KC Weng, Y Ouyang… - Circulation …, 2024 - ahajournals.org
BACKGROUND: The KCNQ1+ KCNE1 (IKs) potassium channel plays a crucial role in
cardiac adaptation to stress, in which β-adrenergic stimulation phosphorylates the IKs …

Cardiac arrhythmias: the growing role of autoantibodies in diagnosis and treatment

FE Fakuade, J Grune, N Voigt - European Heart Journal, 2024 - academic.oup.com
Role of autoantibodies against atrial and ventricular ion channels in cardiac arrhythmias and
their therapeutic potential. Autoantibodies targeting various cardiac ion channels can have …